Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

ACT ENALAPRIL

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ACT ENALAPRIL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ACT ENALAPRIL 4MG has been permanently discontinued (last updated May 28, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ACT ENALAPRIL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength4MG
Report last updated2025-05-28
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

VASOTEC

ORGANON CANADA INC.

16MG · DIN 00670928

Different strengthSame dosage formSame routeNo current shortage

TARO-ENALAPRIL

SUN PHARMA CANADA INC

16MG · DIN 02352265

Different strengthSame dosage formSame routeNo current shortage

ACT ENALAPRIL

TEVA CANADA LIMITED

16MG · DIN 02291908

Different strengthSame dosage formSame routeNo current shortage

ENALAPRIL

SIVEM PHARMACEUTICALS ULC

8MG · DIN 02442973

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02291886

Strength

4MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ENALAPRIL SODIUM

See all ENALAPRIL SODIUM products →

Shortage History